Meridiem Capital Partners LP purchased a new position in shares of Addus HomeCare Co. (NASDAQ:ADUS - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 11,774 shares of the company's stock, valued at approximately $1,476,000. Meridiem Capital Partners LP owned 0.06% of Addus HomeCare at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Summit Place Financial Advisors LLC grew its stake in shares of Addus HomeCare by 0.9% in the 4th quarter. Summit Place Financial Advisors LLC now owns 9,410 shares of the company's stock valued at $1,180,000 after purchasing an additional 80 shares during the last quarter. Janney Montgomery Scott LLC increased its stake in Addus HomeCare by 0.9% in the 4th quarter. Janney Montgomery Scott LLC now owns 10,691 shares of the company's stock valued at $1,340,000 after buying an additional 91 shares during the period. Alliancebernstein L.P. raised its position in Addus HomeCare by 0.5% during the 4th quarter. Alliancebernstein L.P. now owns 19,661 shares of the company's stock worth $2,465,000 after buying an additional 91 shares during the last quarter. Natixis raised its position in Addus HomeCare by 111.9% during the 4th quarter. Natixis now owns 250 shares of the company's stock worth $31,000 after buying an additional 132 shares during the last quarter. Finally, Parkside Financial Bank & Trust boosted its holdings in shares of Addus HomeCare by 38.6% in the fourth quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock valued at $67,000 after acquiring an additional 148 shares in the last quarter. 95.35% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Several research analysts recently issued reports on the stock. StockNews.com cut shares of Addus HomeCare from a "buy" rating to a "hold" rating in a report on Wednesday, February 26th. JMP Securities reissued a "market outperform" rating and issued a $150.00 price target on shares of Addus HomeCare in a report on Tuesday, April 22nd. Oppenheimer raised their price target on Addus HomeCare from $145.00 to $150.00 and gave the company an "outperform" rating in a report on Friday, January 24th. Macquarie raised their price target on Addus HomeCare from $129.00 to $133.00 and gave the company an "outperform" rating in a report on Thursday, May 8th. Finally, Stephens reissued an "overweight" rating and issued a $142.00 price target on shares of Addus HomeCare in a report on Wednesday, March 12th. One investment analyst has rated the stock with a hold rating, six have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Buy" and a consensus target price of $142.57.
Check Out Our Latest Stock Report on ADUS
Addus HomeCare Trading Up 1.6%
Shares of NASDAQ ADUS traded up $1.73 during trading on Friday, reaching $111.63. The company had a trading volume of 158,285 shares, compared to its average volume of 165,612. Addus HomeCare Co. has a twelve month low of $88.96 and a twelve month high of $136.72. The stock has a market capitalization of $2.05 billion, a PE ratio of 25.54, a price-to-earnings-growth ratio of 1.41 and a beta of 0.85. The stock has a 50-day moving average price of $100.30 and a two-hundred day moving average price of $113.74.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its quarterly earnings results on Monday, May 5th. The company reported $1.42 earnings per share for the quarter, topping analysts' consensus estimates of $1.33 by $0.09. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The company had revenue of $337.71 million during the quarter, compared to analysts' expectations of $341.66 million. During the same period in the previous year, the firm posted $1.21 earnings per share. The business's revenue for the quarter was up 20.3% compared to the same quarter last year. On average, sell-side analysts predict that Addus HomeCare Co. will post 4.59 EPS for the current year.
Addus HomeCare Profile
(
Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Read More

Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.